We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where CRISPR ...
19h
Zacks Investment Research on MSNCRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth KnowingCRISPR Therapeutics AG (CRSP) closed the latest trading day at $41.22, indicating a +0.12% change from the previous session's end. This change outpaced the S&P 500's 0.08% gain on the day. On the ...
Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP stock is mainly due to a lack of pipeline updates, which is not sitting ...
CRISPR Therapeutics (NASDAQ: CRSP) soared a couple of years ago as it brought Casgevy, its blood disorders treatment, from late-stage development to regulatory approval. This is the first approved ...
The latest trading session saw CRISPR Therapeutics AG (CRSP ... Elsewhere, the Dow saw a downswing of 0.03%, while the tech-heavy Nasdaq depreciated by 0.33%. The company's shares have seen ...
Zurcher Kantonalbank Zurich Cantonalbank raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.0% in ...
A month has gone by since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have added about 0.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...
Farther Finance Advisors LLC boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 34.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) fell 2.9% on Thursday after an insider sold shares in the company. The company traded as low as $42.78 and last traded at $42.22. 282,558 shares ...
Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...
1d
Zacks Investment Research on MSNCRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for InvestorsThe latest trading session saw CRISPR Therapeutics AG (CRSP) ending at $41.17, denoting a -1.84% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily loss of 0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results